Proficio Capital Partners LLC trimmed its position in shares of CVS Health Corporation (NYSE:CVS) by 0.6% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,157 shares of the pharmacy operator’s stock after selling 78 shares during the quarter. Proficio Capital Partners LLC’s holdings in CVS Health Corporation were worth $1,049,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. raised its holdings in CVS Health Corporation by 3.2% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 176,294 shares of the pharmacy operator’s stock worth $13,840,000 after purchasing an additional 5,478 shares during the period. Fiduciary Trust Co. raised its holdings in CVS Health Corporation by 1.2% in the 1st quarter. Fiduciary Trust Co. now owns 366,007 shares of the pharmacy operator’s stock worth $28,732,000 after purchasing an additional 4,265 shares during the period. British Columbia Investment Management Corp raised its holdings in CVS Health Corporation by 3.7% in the 1st quarter. British Columbia Investment Management Corp now owns 561,299 shares of the pharmacy operator’s stock worth $44,062,000 after purchasing an additional 19,794 shares during the period. Independent Advisor Alliance raised its holdings in CVS Health Corporation by 6.7% in the 1st quarter. Independent Advisor Alliance now owns 26,460 shares of the pharmacy operator’s stock worth $2,038,000 after purchasing an additional 1,652 shares during the period. Finally, Bahl & Gaynor Inc. raised its holdings in CVS Health Corporation by 1.1% in the 1st quarter. Bahl & Gaynor Inc. now owns 14,922 shares of the pharmacy operator’s stock worth $1,171,000 after purchasing an additional 167 shares during the period. 81.46% of the stock is currently owned by hedge funds and other institutional investors.

CVS has been the topic of a number of recent research reports. Royal Bank Of Canada initiated coverage on CVS Health Corporation in a report on Tuesday, September 19th. They issued an “outperform” rating and a $95.00 target price on the stock. Leerink Swann set a $90.00 target price on CVS Health Corporation and gave the stock a “buy” rating in a report on Tuesday, June 27th. Robert W. Baird reaffirmed an “outperform” rating and issued a $90.00 target price on shares of CVS Health Corporation in a report on Monday, August 14th. Loop Capital initiated coverage on CVS Health Corporation in a report on Thursday, August 24th. They issued a “hold” rating and a $83.00 target price on the stock. Finally, Jefferies Group LLC set a $86.00 target price on CVS Health Corporation and gave the stock a “hold” rating in a report on Wednesday, October 18th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and sixteen have issued a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $89.68.

COPYRIGHT VIOLATION NOTICE: “CVS Health Corporation (CVS) Shares Sold by Proficio Capital Partners LLC” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this report can be read at https://www.thecerbatgem.com/2017/10/23/cvs-health-corporation-cvs-shares-sold-by-proficio-capital-partners-llc.html.

In related news, Director Richard J. Swift sold 2,500 shares of the company’s stock in a transaction dated Wednesday, August 16th. The shares were sold at an average price of $79.62, for a total transaction of $199,050.00. Following the completion of the transaction, the director now owns 3,258 shares in the company, valued at approximately $259,401.96. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Thomas M. Moriarty sold 20,547 shares of the company’s stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $81.17, for a total transaction of $1,667,799.99. Following the transaction, the executive vice president now owns 43,178 shares of the company’s stock, valued at approximately $3,504,758.26. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 716,625 shares of company stock valued at $58,318,431. Insiders own 0.61% of the company’s stock.

CVS Health Corporation (CVS) opened at 76.49 on Monday. The stock has a market cap of $77.76 billion, a price-to-earnings ratio of 15.24 and a beta of 0.92. CVS Health Corporation has a 12 month low of $69.30 and a 12 month high of $88.58. The stock’s 50 day moving average price is $78.86 and its 200-day moving average price is $78.71.

CVS Health Corporation (NYSE:CVS) last released its quarterly earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share for the quarter, topping the consensus estimate of $1.31 by $0.02. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. The firm had revenue of $45.69 billion during the quarter, compared to the consensus estimate of $45.36 billion. During the same quarter in the prior year, the firm earned $1.32 EPS. The company’s revenue for the quarter was up 4.5% on a year-over-year basis. Equities analysts expect that CVS Health Corporation will post $5.88 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, November 3rd. Investors of record on Tuesday, October 24th will be given a dividend of $0.50 per share. The ex-dividend date is Monday, October 23rd. This represents a $2.00 annualized dividend and a dividend yield of 2.61%. CVS Health Corporation’s dividend payout ratio (DPR) is presently 39.92%.

CVS Health Corporation Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.